High stress hormone levels accelerate the onset of memory deficits in male Huntington's disease mice

被引:25
作者
Mo, Christina [1 ,2 ]
Pang, Terence Y. [1 ]
Ransome, Mark I. [1 ,2 ]
Hill, Rachel A. [1 ,2 ]
Renoir, Thibault [1 ,2 ]
Hannan, Anthony J. [1 ,2 ]
机构
[1] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3010, Australia
[2] Univ Melbourne, Dept Anat & Neurosci, Parkville, Vic 3010, Australia
关键词
Huntington's disease; Corticosterone treatment; Stress hormone; Short-term memory; HPA axis; Cell proliferation; TrkB; TRANSGENIC MOUSE MODEL; PITUITARY-ADRENAL AXIS; BDNF MESSENGER-RNA; NEUROTROPHIC FACTOR; HIPPOCAMPAL NEUROGENESIS; CHRONIC CORTICOSTERONE; SYNAPTIC PLASTICITY; SPATIAL MEMORY; MINERALOCORTICOID RECEPTOR; PROGENITOR PROLIFERATION;
D O I
10.1016/j.nbd.2014.05.004
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Huntington's disease (HD) is a neurodegenerative disorder caused by a tandem repeat mutation in the huntingtin gene. Lifestyle factors, such as lack of activity may contribute to the variability in the age of disease onset. Therefore, better understanding of environmental modifiers may uncover potential therapeutic approaches to delay disease onset and progression. Recent data suggest that HD patients and transgenic mouse models show a dysregulated stress response. In this present study, we elevated stress hormone levels through oral corticosterone (CORT) treatment and assessed its impact on the development of motor impairment and cognitive deficits using the R6/1 transgenic mouse model of HD. We found that CORT consumption did not alter rotarod performance of R6/1 HD or wild-type (WT) littermates. However, the onset of hippocampal-dependent Y-maze deficits was accelerated in male R6/1 mice by 5 days of CORT treatment, whereas short term memory of WT and female R6/1 mice was unaffected. We then further investigated the male HD susceptibility to CORT by measuring TrkB activation, BDNF and glucocorticoid receptor expression as well as the level of cell proliferation in the hippocampus. CORT treatment increased the levels of phosphorylated TrkB in male R6/1 mice only. There were no effects of CORT on hippocampal BDNF protein or mRNA levels; nor on expression of the glucocorticoid receptors in any group. Hippocampal cell proliferation was decreased in male R6/1 mice and this was further reduced in CORT-drinking male R6/1 mice. Female mice (WT and R6/1) appeared to be protected from the impacts of CORT treatment in all our hippocampal measures. Overall, our data demonstrate that treatment with corticosterone is able to modulate the onset of HD symptomatology. We present the first evidence of a male-specific vulnerability to stress impacting on the development of short-term memory deficits in HD. More generally, we found that female mice were protected from the detrimental effects of CORT treatment on a variety of hippocampus-based measures. Hippocampal plasticity and memory in HD may be more susceptible to the impacts of stress in a sex-dependent manner. We propose clinical investigations of stress as a key environmental modifier of HD symptom onset. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:248 / 262
页数:15
相关论文
共 103 条
  • [1] Synaptic plasticity: taming the beast
    Abbott, L. F.
    Nelson, Sacha B.
    [J]. NATURE NEUROSCIENCE, 2000, 3 (11) : 1178 - 1183
  • [2] The exercise-induced expression of BDNF within the hippocampus varies across life-span
    Adlard, PA
    Perreau, VM
    Cotman, CW
    [J]. NEUROBIOLOGY OF AGING, 2005, 26 (04) : 511 - 520
  • [3] Increased Hypothalamic-Pituitary-Adrenal Axis Activity in Huntington's Disease
    Aziz, N. Ahmad
    Pijl, Hanno
    Frolich, Marijke
    van der Graaf, A. W. Maurits
    Roelfsema, Ferdinand
    Roos, Raymund A. C.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (04) : 1223 - 1228
  • [4] Barnabé-Heider F, 2003, J NEUROSCI, V23, P5149
  • [5] Birt DF, 2001, CANCER EPIDEM BIOMAR, V10, P679
  • [6] Progressive alterations in the hypothalamic-pituitary-adrenal axis in the R6/2 transgenic mouse model of Huntington's disease
    Björkqvist, M
    Petersén, Å
    Bacos, K
    Isaacs, J
    Norlén, P
    Gil, J
    Popovic, N
    Sundler, F
    Bates, GP
    Tabrizi, SJ
    Brundin, P
    Mulder, H
    [J]. HUMAN MOLECULAR GENETICS, 2006, 15 (10) : 1713 - 1721
  • [7] Beyond the patient: The broader impact of genetic discrimination among individuals at risk of Huntington disease
    Bombard, Yvonne
    Palin, JoAnne
    Friedman, Jan M.
    Veenstra, Gerry
    Creighton, Susan
    Bottorff, Joan L.
    Hayden, Michael R.
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2012, 159B (02) : 217 - 226
  • [8] Imbalance of p75NTR/TrkB protein expression in Huntington's disease: implication for neuroprotective therapies
    Brito, V.
    Puigdellivol, M.
    Giralt, A.
    del Toro, D.
    Alberch, J.
    Gines, S.
    [J]. CELL DEATH & DISEASE, 2013, 4 : e595 - e595
  • [9] CHRONIC HIGH CORTICOSTERONE REDUCES NEUROGENESIS IN THE DENTATE GYRUS OF ADULT MALE AND FEMALE RATS
    Brummelte, S.
    Galea, L. A. M.
    [J]. NEUROSCIENCE, 2010, 168 (03) : 680 - 690
  • [10] WHICH FACTORS INFLUENCE AGE AT ONSET AND RATE OF PROGRESSION IN HUNTINGTONS-DISEASE
    BURUMA, OJS
    VANDERKAMP, W
    BARENDSWAARD, EC
    ROOS, RAC
    KROMHOUT, D
    VANDERVELDE, EA
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 1987, 80 (2-3) : 299 - 306